Last edition
News about Biotechnology
MaxCyte, Inc., a leading provider of cell-engineering platform technologies, announced the signing of a clinical and commercial license with Sana Biotechnology, Inc., a company focused on creating and delivering engineered cells as medicines.
Biotechnology | 10/08/2021 | By Darshana | 322
Pharmexcil seeks list of products requiring SION norms fixation from exporters
The Pharmaceutical Export Promotion Council of India (Pharmexcil) has asked exporters to provide a list of products requiring Standard Input Output Norms (SION) fixation to help them fulfill export obligations in a timely manner
Biotechnology | 02/08/2021 | By Darshana | 349
Ascentage Pharma and Innovent Biologics announced a multifaceted strategic collaboration. This collaboration includes the joint clinical development and commercialization of HQP1351(olverembatinib), a third-generation BCR-ABL inhibitor and a core drug candidate of Ascentage Pharma
Biotechnology | 16/07/2021 | By Darshana | 458
Abbott gets CDSCO approval for marketing of estradiol, dydrogesterone FDC
Abbott, the global healthcare company, has received approval from the Subject Expert Committee (SEC) at Central Drugs Standard Control Organisation (CDSCO) for importing and marketing of the fixed dose combination of dydrogesterone+estradiol (2.5 mg + 0.5mg) tablets
Biotechnology | 15/07/2021 | By Darshana | 306
Lupin gets US FDA nod to market generic Kerydin topical solution
Global pharma major Lupin Limited announced the US launch of tavaborole topical solution, 5% having received an approval from the United States Food and Drug Administration (FDA)
Biotechnology | 13/07/2021 | By Darshana | 271
IGBA launches a whitepaper: A vision for the generic and biosimilar medicines industry
The International Generic and Biosimilar Medicines Association (IGBA) has announced the launch of a whitepaper: A vision for the generic and biosimilar medicines industry, which covers the strong contribution of this pharmaceutical sector to global health outcomes and economies, the opportunities, challenges and disruptions for the industry
Biotechnology | 08/07/2021 | By Darshana | 203
CGT Catapult to expand to Edinburgh BioQuarter to speed up product development
The Cell and Gene Therapy Catapult (CGT Catapult), an independent centre of excellence to advance the growth of the UK cell and gene therapy industry, by bridging the gap between scientific research and full-scale commercialisation
Biotechnology | 02/07/2021 | By Darshana | 182
Alembic Pharma receives US FDA approval for generic Macrodantin capsules
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for nitrofurantoin capsules, USP (Macrocrystals), 25 mg, 50 mg and 100 mg
Biotechnology | 01/07/2021 | By Darshana | 173
Dr. Reddy's Labs announces commercial launch of 2-DG
Dr Reddy's will supply to major government as well as private hospitals across India. In the initial weeks, the company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India
Biotechnology | 28/06/2021 | By Darshana | 164
Biomerica inks pact with Canadian partner to distribute & market Helicobacter pylori test, hp+detect
Biomerica announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary Helicobacter pylori test, called hp+detect
Biotechnology | 26/06/2021 | By Darshana | 149
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy